Vaccines are a clinical product that is composed of live or dead material from an infectious agent – bacterium, virus, fungus or parasite – that elicit protective immunity against the pathogen ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, today ...

RabAvert, an approved inactivated virus vaccine, was included as an active comparator arm. All dose levels of RBI-4000 tested, including those as low as 0.1 mcg, elicited de novo protective immune ...

RBI-4000's potential to offer a meaningful improvement over existing vaccines for rabies, an ongoing global public health concern, supports further development SAN DIEGO, Feb. 7, 2025 /PRNewswire ...

The panel voted 14-13 along party lines with Democrats having accused Kennedy over two days of contentious confirmation hearings of being financially vested in the anti-vaccine movement and ...

The expected revenue is comprised of DKK 3,000 – 4,000 million from Public Preparedness vaccines, of which DKK 2,500 million have already been secured by contracts. Furthermore, approximately ...